Trial intelligence / Profile preview

DFD01 Spray vs Vehicle Spray in Moderate Psoriasis

NCT01967069Phase 3Completed

Sponsor
Primus Pharmaceuticals
Start
Nov 2013
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in plaque psoriasis comparing DFD01 Spray with Vehicle Spray (2 arms). Primary endpoint: Percentage of Participants With Treatment Success According to the Investigator's Global Assessment at Day 15. Started Nov 2013; status: completed.

02

Drugs

betamethasone dipropionate spray 0.05%
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01967069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01967069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call